Baker Brothers Advisors - KARYOPHARM THERAPEUTICS INC ownership

KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 54 filers reported holding KARYOPHARM THERAPEUTICS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
Baker Brothers Advisors ownership history of KARYOPHARM THERAPEUTICS INC
ValueSharesWeighting
Q4 2017$2,083,000
-12.6%
216,9900.0%0.02%
-5.3%
Q3 2017$2,383,000
+21.3%
216,9900.0%0.02%
+11.8%
Q2 2017$1,964,000
-29.5%
216,9900.0%0.02%
-26.1%
Q1 2017$2,786,000
+36.6%
216,9900.0%0.02%
+15.0%
Q4 2016$2,040,000
-3.4%
216,9900.0%0.02%
+5.3%
Q3 2016$2,111,000
+45.0%
216,9900.0%0.02%
+26.7%
Q2 2016$1,456,000
-24.8%
216,9900.0%0.02%
-25.0%
Q1 2016$1,936,000
-32.7%
216,9900.0%0.02%
-16.7%
Q4 2015$2,875,000
+25.8%
216,9900.0%0.02%
+14.3%
Q3 2015$2,285,000
-61.3%
216,9900.0%0.02%
-59.6%
Q2 2015$5,904,000
-11.1%
216,9900.0%0.05%
-5.5%
Q1 2015$6,642,000
+88.6%
216,990
+130.6%
0.06%
+52.8%
Q4 2014$3,522,000
+7.1%
94,0950.0%0.04%
-12.2%
Q3 2014$3,288,000
-24.9%
94,0950.0%0.04%
-24.1%
Q2 2014$4,380,000
+140.0%
94,095
+59.2%
0.05%
+134.8%
Q1 2014$1,825,000
+29.8%
59,095
-3.6%
0.02%
+15.0%
Q4 2013$1,406,00061,3300.02%
Other shareholders
KARYOPHARM THERAPEUTICS INC shareholders Q4 2013
NameSharesValueWeighting ↓
Consonance Capital Management LP 7,180,700$137,941,00010.27%
Palo Alto Investors LP 4,299,901$82,601,0006.92%
Fairmount Funds Management LLC 562,351$10,803,0006.55%
Avoro Capital Advisors LLC 7,000,000$134,470,0004.54%
Pinz Capital Management, LP 8,820$1,694,0004.44%
Birchview Capital, LP 148,000$2,843,0002.52%
Elk Creek Partners, LLC 699,951$13,446,0002.31%
Parkman Healthcare Partners LLC 215,802$4,146,0001.92%
EAM Global Investors LLC 136,402$2,620,0001.53%
SPHERA FUNDS MANAGEMENT LTD. 550,000$10,566,0001.32%
View complete list of KARYOPHARM THERAPEUTICS INC shareholders